Jim Cramer's Lightning Round: Cintas, Tandem Diabetes, Phillips 66, ISRG, Verive Holdings

Tandem Diabetes Care (TNDM)

• 💡 A caller's son and grandson use Tandem diabetes pumps, with a new wireless pump similar to a human pancreas expected in 6-8 months.
• ⚠️ Despite the company losing money, Cramer views it as a speculative stock for younger people with their whole lives ahead of them.

Cintas (CTAS)

• 🎯 Cramer suggests buying Cintas when people anticipate a hiring slowdown and not when the stock is already high.
• 📈 His strategy is to buy some now, wait for the next quarter, and buy more if the quarter is disappointing, as it's a great long-term hold.

Phillips 66 (PSX)

• ⚡ Cramer approves of buying Phillips 66 when oil prices are going down, liking the current spread and advising to "pull the trigger."

Intuitive Surgical (ISRG)

• ⚠️ Cramer is hesitant to buy ISRG despite liking it for a long time, citing a disappointing last quarter and ongoing bullpen refresh.
• 📌 He mentions a discussion with Jeff Barks and that the stock has come down, but he's not pulling the trigger yet.

Verive Holdings (VRV)

• 🚀 Verive is highlighted as a stock to add to the bullpen due to strong data center numbers, similar to those seen from Oracle.
• 🛠️ The company is noted for doing private label manufacturing of air conditioners for other well-known companies.